0001209191-19-047446.txt : 20190826 0001209191-19-047446.hdr.sgml : 20190826 20190826193347 ACCESSION NUMBER: 0001209191-19-047446 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190822 FILED AS OF DATE: 20190826 DATE AS OF CHANGE: 20190826 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chung Christine CENTRAL INDEX KEY: 0001775295 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 191054063 MAIL ADDRESS: STREET 1: C/O FIBROGEN, INC. STREET 2: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-22 0 0000921299 FIBROGEN INC FGEN 0001775295 Chung Christine C/O FIBROGEN, INC. 409 ILLINOIS ST. SAN FRANCISCO CA 94158 0 1 0 0 SVP, China Operations Common Stock 2019-08-22 4 M 0 5625 19.39 A 157195 D Common Stock 2019-08-22 4 S 0 5325 43.79 D 151870 D Common Stock 2019-08-22 4 S 0 300 44.67 D 151570 D Common Stock 2019-08-23 4 M 0 5625 19.39 A 157195 D Common Stock 2019-08-23 4 S 0 3225 42.05 D 153970 D Common Stock 2019-08-23 4 S 0 1816 42.94 D 152154 D Common Stock 2019-08-23 4 S 0 584 43.68 D 151570 D Stock Option (Right to Buy) 19.39 2019-08-22 4 M 0 5625 0.00 D 2026-02-22 Common Stock 5625 58579 D Stock Option (Right to Buy) 19.39 2019-08-23 4 M 0 5625 0.00 D 2026-02-22 Common Stock 5625 52954 D Shares sold pursuant to a 10b5-1 plan. The shares were sold at prices ranging from $43.47 to $44.29. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $44.62 to $44.72. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $41.61 to $42.57. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $42.61 to $43.60. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $43.61 to $43.79. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Twenty-five percent of the shares subject to the option vested on March 1, 2017, and the remainder vest in equal amounts quarterly thereafter for the following three years. /s/ Dorothy Pacini, Attorney-in-fact 2019-08-26